Radiotherapy of morphea-type basal-cell carcinomas

M. Caccialanza, R. Piccinno, E. Drudi

Research output: Contribution to journalArticle

Abstract

Morphea-type carcinomas are the most difficult to cure among the basal- cell carcinomas. The data regarding the response to radiotherapy of this form are few and not univocal. For this reason, a retrospective study was performed with 20 patients affected by morphea-type basal-cell carcinoma, who underwent orthovoltage radiotherapy in the period 1982-1998. Complete remission was obtained in 85% of the irradiated lesions. The two-year cure- rate was 86.11%. The cosmetic results were good or acceptable in 94.11% of cases. One acute radiodermatitis occurred. Such results make us think that radiotherapy of these tumours is possible and is particularly indicated for selected cases.

Original languageEnglish
Pages (from-to)233-238
Number of pages6
JournalSkin Cancer
Volume14
Issue number4
Publication statusPublished - 1999

Keywords

  • Morphea-type basal-cell carcinoma
  • Radiotherapy
  • Sclerosing-type basal- cell carcinoma

ASJC Scopus subject areas

  • Dermatology
  • Oncology

Fingerprint Dive into the research topics of 'Radiotherapy of morphea-type basal-cell carcinomas'. Together they form a unique fingerprint.

  • Cite this

    Caccialanza, M., Piccinno, R., & Drudi, E. (1999). Radiotherapy of morphea-type basal-cell carcinomas. Skin Cancer, 14(4), 233-238.